Abstract:Objective:To explore the predictors of glucocorticoid application in children with infectious mononucleosis (IM).Methods:The clinical data of 554 children with IM admitted in Children’s Hospital, Zhejiang University School of Medicine from January 2012 to December 2017 were retrospectively analyzed. The patients were divided into improved cases ( n=436) and deteriorated cases ( n=118), according the clinical conditions at day 7 after admission. The clinical characteristics and baseline laboratory examination results of the two groups were analyzed by univariate analysis. The important variables were screened by random forest model, and then included into the binary logistic regression model to analyze the risk factors for deteriorated IM. Receiver operating characteristic (ROC) curve was used to evaluate the value of each factor in predicting deteriorated IM. The area under curve (AUC) of each factor was compared by MedCalc 19 statistical software. Then, 141 patients admitted in 2018 who met the predictors were given glucocorticoid, and the changes of clinical and laboratory indicators were compared. SPSS 20.0 software was used to analyze the data. Results:Binary logistic regression analysis showed that febrile time ( OR=1.493, 95% CI 1.372-1.626, P<0.01), involved systems ( OR=2.023, 95% CI 1.453-2.817, P<0.01) and ferritin level ( OR=1.002, 95% CI 1.000-1.004, P<0.05) were the independent risk factors of deterioration of IM patients. The AUC of febrile time was 0. 854, when the cut-off value was 10 d, the sensitivity and specificity for prediction were 75.4% and 86.9%, respectively. AUC of involved systems and ferritin level were 0.640 and 0.607, respectively. Compared with the involved systems and ferritin level, febrile time had a higher value in predicting deteriorated cases ( P<0.01). Among 141 IM patients admitted in 2018, 23 cases had fever for more than 10 days, and glucocorticoids were administrated; in whom 20 cases (87.0%) had temperature dropped on the same day, and 21 cases (91.3%) had temperature returned to normal within 3 days. The body temperature dropped within 2 days after glucocorticoid, and was back to normal within 5 days in all children. The white blood cell count, lymphocyte count, lymphocyte count, serum ferritin, serum EBV DNA load and interleukin 6 level were also significantly decreased ( P<0.05 or <0.01). No EBV reactivation was found during the follow-up period of 22 to 34 months. Conclusions:IM children with persistent illness often present with a persistent fever, more involved systems, and increased ferritin levels. It is necessary to give the patients therapy with glucocorticoid to control their illness.

Rapid recovery in a child with febrile ulceronecrotic Mucha‐Habermann disease following intravenous immunoglobulin administration

Febrile Ulceronecrotic Mucha-Habermann Disease: Treatment with Infliximab and Intravenous Immunoglobulins and Review of the Literature

Application of glucocorticoids in children with infectious mononucleosis

Febrile ulceronecrotic Mucha–Habermann disease following suspected hemorrhagic chickenpox infection in a 20-month-old boy

Case Report: Macrophage Activation Syndrome and Widespread Neuroimaging Abnormality in Childhood-Onset Systemic Lupus Erythematosus

A case report of febrile ulceronecrotic Mucha-Habermann disease

Mucha‐Habermann disease: a pediatric case report and proposal of a risk score

Eculizumab as first-line treatment for patients with severe presentation of complement factor H antibody-mediated hemolytic uremic syndrome

Febrile Ulceronecrotic Mucha-Habermann Disease Associated With Hemophagocytic Lymphohistiocytosis: A Case Report and Review of the Literature

Rapidly Progressive Idiopathic Pyoderma Gangrenosum in a Pediatric Patient Successfully Treated With Infliximab

Curative Effects of Immunoglobulin in the Treatment of the Sever Hand-foot-mouth Disease

Clinical Efficacy of Early Administration of Human Immunoglobulin on Children with Severe Hand-foot-mouth Disease

Successful Treatment of Rapidly Progressive Interstitial Lung Disease in Juvenile Dermatomyositis

Febrile ulceronecrotic Mucha-Habermann disease - a case and treatment review

An 8-month-old boy with purpuric skin lesions. Acute hemorrhagic edema of infancy

Pediatric atypical hemolytic–uremic syndrome due to auto-antibodies against factor H: is there an interest to combine eculizumab and mycophenolate mofetil?

Fatal visceral disseminated varicella zoster infection during initial remission induction therapy in a patient with lupus nephritis and rheumatoid arthritis-possible association with mycophenolate mofetil and high-dose glucocorticoid therapy: a case report

Successful treatment of fulminant myocarditis with intra-aortic balloon pump counterpulsation combined with immunoglobulin and glucocorticoid in a young male adult

Methotrexate Treatment in Children with Febrile Ulceronecrotic Mucha-Habermann Disease: Case Report and Literature Review

Successful Treatment of Disseminated Fusariosis in a 15-Month-Old Boy With Refractory Acute Lymphoblastic Leukemia Using High-Dose Voriconazole

Case report: A novel high‐dose intravenous immunoglobulin preparation for the treatment of severe pemphigus vulgaris failing standard therapy